Table 2.
Cost of treatments and relative sources
| Unit cost | Total cost for 4 weeks | Source | |
|---|---|---|---|
| Topical drugs | |||
| Dovobet® gel | €33.17 | €30.96 | AIFA transparency lists 201135 |
| Dovobet® ointment | €27.99 | €26.12 | AIFA transparency lists 201135 |
| Phototherapy | |||
| UV-light treatment* | €5.00 | €60.00 | Colombo et al.18 Moderate and severe plaque psoriasis: cost-of-illness study in Italy |
| Conventional systemic drugs | |||
| Acitretin | €32.73 | €45.82 | AIFA transparency lists 201135 |
| Methotrexate | €38.47 | €38.47 | AIFA transparency lists 201135 |
| Cyclosporine | €22.59 | €265.66 | AIFA transparency lists 201135 |
| Weighted mean | €149.43 | ||
| Biotechnological drugs | |||
| Infliximab | €542.14 | €1,275.12 | AIFA transparency lists 2011 – ex factory prices35 |
| Infliximab – administration | €22.51 | €3.78 | AIFA transparency lists 2011 – ex factory prices35 |
| Adalimumab 40 mg | €1,015.12 | €1,092.27 | AIFA transparency lists 2011 – ex factory prices35 |
| Etanercept 50 mg | €969.62 | €969.62 | AIFA transparency lists 2011 – ex factory prices35 |
| Etanercept 25 mg | €484.74 | €969.48 | AIFA transparency lists 2011 – ex factory prices35 |
| Ustekinumab 45 mg | €2,842.88 | €1,341.84 | AIFA transparency lists 2011 – ex factory prices35 |
| Weighted mean | €807.24 | ||
| Visits | |||
| General practitioner visit | €22.51 | €22.51 | Outpatient visit hospital rates36 |
| Dermatologist | €22.51 | €22.51 | Outpatient visit hospital rates36 |
Note:
*
Treatment per session.
Abbreviations: AIFA, Italian Medicines Agency.